| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/08/2004 | CN1552343A Sodium alginate diester drops and their preparing method |
| 12/08/2004 | CN1552342A Medicine for preventing gynaecological disease |
| 12/08/2004 | CN1552341A Medicine for preventing diabets mellitus |
| 12/08/2004 | CN1552340A Medicine for preventing nephroma |
| 12/08/2004 | CN1552339A Methyleritrocina injection |
| 12/08/2004 | CN1552338A Medicine for preventing cardiovascular disease |
| 12/08/2004 | CN1552337A Medicine for preventing cerebrovascular disease |
| 12/08/2004 | CN1552336A Medicine for preventing prostatic disorders |
| 12/08/2004 | CN1552335A Ginseng and ophiopogon saponin drops and their preparing method |
| 12/08/2004 | CN1552334A Medicinal composition for treating cardiovascular disease |
| 12/08/2004 | CN1552333A Medicine for preventing depression |
| 12/08/2004 | CN1552332A Enteric sotuble preparation of Adefuwei double-graded valeryl oxomethyl ester |
| 12/08/2004 | CN1552331A Improvement of chronic mild stress BALB/C mouse depression by compound 7-carbonyl epiandrosterone |
| 12/08/2004 | CN1552330A Paint for treating benign prostate hyperplasia and its use |
| 12/08/2004 | CN1552329A Powder injection of cefpiramide |
| 12/08/2004 | CN1552328A Use of phenoxthine compounds in preparing medicnies for inhibiting cancers and promoting radio-sensitive medicines |
| 12/08/2004 | CN1552327A Oral ofloxacin control-sustained releasing medicinal composition |
| 12/08/2004 | CN1552326A Method for stabilizing intravenous injection of azasejoin |
| 12/08/2004 | CN1552325A Doxofyline osmotic pump controlled releasing preparation and its production |
| 12/08/2004 | CN1552324A Medicinal composition for stabilizing delotadine in preparation |
| 12/08/2004 | CN1552323A Monolayer osmotic pump controlled releasing tablets of nimodipine |
| 12/08/2004 | CN1552322A Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 12/08/2004 | CN1552321A Use of Abidol in preparing medicines for treating and preventing SARS virus |
| 12/08/2004 | CN1552320A Andrographolide compound solubilizing preparing method and medicinal preparation |
| 12/08/2004 | CN1552319A Bilobanone drops |
| 12/08/2004 | CN1552318A Hawthorn leave flavone capsules and their preparing method |
| 12/08/2004 | CN1552317A Preparation of Xindakang |
| 12/08/2004 | CN1552316A Houttuynia cordata sodium cyclodextrin dressing material, preparation and preparing method thereof |
| 12/08/2004 | CN1552315A 治疗组合物 The therapeutic composition |
| 12/08/2004 | CN1552314A Antibacterial medicinal composition |
| 12/08/2004 | CN1552311A Oral dissolved fenofibrate tablets |
| 12/08/2004 | CN1552310A Preparation of powder agglomerates |
| 12/08/2004 | CN1552309A Method for promoting solid cilostazol to dissolve out |
| 12/08/2004 | CN1179047C Method for introducing substances into cells and use of said method |
| 12/08/2004 | CN1179046C Erythromycins and its preparation method, use and compositions |
| 12/08/2004 | CN1179026C Fat compositions |
| 12/08/2004 | CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA |
| 12/08/2004 | CN1178951C Noval erythromycin derivatives and its preparing method and its use thereof as drugs |
| 12/08/2004 | CN1178941C CRF receptor antagonists and method relating thereof |
| 12/08/2004 | CN1178940C Selective antagonists of A28 adenosine receptors |
| 12/08/2004 | CN1178939C Non-nucleoside reverse transcriptase inhibitors |
| 12/08/2004 | CN1178938C 1,2-annelated quinoline derivatives |
| 12/08/2004 | CN1178936C Sulfonyl-pyrrolidine derivatives |
| 12/08/2004 | CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 12/08/2004 | CN1178934C Benzofurane derivatives |
| 12/08/2004 | CN1178932C Amide derivatives |
| 12/08/2004 | CN1178931C Substituted pyrazole compounds |
| 12/08/2004 | CN1178927C Histamine H3 receptor ligands |
| 12/08/2004 | CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 12/08/2004 | CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 12/08/2004 | CN1178921C Preparation of sulfonamides |
| 12/08/2004 | CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 12/08/2004 | CN1178915C Alkynyl containing hydroxamic acid derivatives and its preparation and its use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors |
| 12/08/2004 | CN1178914C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol |
| 12/08/2004 | CN1178913C Aromatic heterocycle compounds having HIV integrase inhibiting activities |
| 12/08/2004 | CN1178912C Small molecule inhibitors of rotamase enzyme activity |
| 12/08/2004 | CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders |
| 12/08/2004 | CN1178907C 3-(fatty acid)-1,2 gluceride disulfate and its preparing method and application |
| 12/08/2004 | CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 12/08/2004 | CN1178905C Novel peptide derivative |
| 12/08/2004 | CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound |
| 12/08/2004 | CN1178900C Anti-tumour agents |
| 12/08/2004 | CN1178895C Naprosyn precusor and its synthesis method and its application |
| 12/08/2004 | CN1178890C Method for extracting hypericin from hypericum perforatum |
| 12/08/2004 | CN1178889C Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same |
| 12/08/2004 | CN1178699C Pharmaceutical compositions containing compounds with activity for enhancement of absorption of active ingredients |
| 12/08/2004 | CN1178696C Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor |
| 12/08/2004 | CN1178694C Use of IL-12 and IFN-'alpha' for treatment of infectiong diseases |
| 12/08/2004 | CN1178688C Health-care food for resisting fatigue |
| 12/08/2004 | CN1178687C Compound seabuckthorn fruit oil suppository |
| 12/08/2004 | CN1178680C Medicine of treating dermatosis for external use |
| 12/08/2004 | CN1178668C Use of Chinese angelica polysaccharide in oral colon orientation releasing pro-drug |
| 12/08/2004 | CN1178667C Glycosaminoglycans having average molecular weight equal to 2400 D suitable for treatment of senile dementia |
| 12/08/2004 | CN1178666C Gypenoside drip pill, and preparing process thereof |
| 12/08/2004 | CN1178665C Water soluble prodrugs of azole compounds |
| 12/08/2004 | CN1178664C Remedy for axillary osmidrosis containing adrenocorticosteriodal preparation |
| 12/08/2004 | CN1178663C Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance |
| 12/08/2004 | CN1178662C Oral 2-methyl-thieno-benzodiazepine formulation |
| 12/08/2004 | CN1178661C Use of brinzolamide to prevent visual field loss |
| 12/08/2004 | CN1178660C Antiviral combinations of lamivudine and adefovir |
| 12/08/2004 | CN1178659C Madicament formulation with controlled release of active agent |
| 12/08/2004 | CN1178658C Process for synthesizing Cox-2 inhibitors |
| 12/08/2004 | CN1178657C Treatment and prophylaxis of pancreatitis |
| 12/08/2004 | CN1178656C Pharmaceutical composition |
| 12/08/2004 | CN1178655C Water-miscible pharmaceutical compositions of paclitaxel |
| 12/08/2004 | CN1178654C Chloromycetin kibe ointment |
| 12/08/2004 | CN1178653C Drug composition |
| 12/08/2004 | CN1178652C Mizoribine tablet with improved colour |
| 12/08/2004 | CN1178651C Lyophilized thioxanthenone anti-tumor agents |
| 12/08/2004 | CN1178650C Multiple unit controlled non-independent release pharmaceutical preparations and method for preparing same |
| 12/08/2004 | CN1178649C Copmound zinc undecylenate ointment for treating beriberi |
| 12/08/2004 | CN1178648C Use of H+, K+-ATPase inhibitors in preparing oral medicine for enhancing inhibition of gastric acid secretion |
| 12/08/2004 | CN1178642C Oral care compositions |
| 12/08/2004 | CN1178639C Washing cosmetic composition and use thereof |
| 12/08/2004 | CN1178592C Drinks and foods capable of eliminating helicobacter pylori |
| 12/07/2004 | US6828473 Transgenic mammal for use in the treatment of cancer and inflammatory disease |
| 12/07/2004 | US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists |
| 12/07/2004 | US6828458 Topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 12/07/2004 | US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 12/07/2004 | US6828451 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |